KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
No Result
View All Result
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Healthcare

KT Develops Next-Gen Neuro-Electronic Therapy Tech with NeuroSigma

 925 total views,  1 views today

Minseo Park by Minseo Park
PUBLISHED: June 16, 2021 UPDATED: June 17, 2021
in Healthcare, KT, Tech Industry
0
KT signed an MOU with Monarch eTNS System developer NeuroSigma to develop and commercialize electronic treatments for numerous neurological conditions.
KT signed an MOU with Monarch eTNS System developer NeuroSigma to develop and commercialize electronic treatments for numerous neurological conditions.

KT signed an MOU with Monarch eTNS System developer NeuroSigma to develop and commercialize electronic treatments for numerous neurological conditions.

KT Corp. announced that it had signed a memorandum of understanding (MOU) with NeuroSigma Inc., establishing a strategic partnership. The South Korean telecom operator plans to strengthen its healthcare industry foothold through the NeuroSigma collaboration. Under the MOU, KT and NeuroSigma would develop and commercialize electronic therapy technologies for neurological and neuropsychological conditions. Some of the conditions the technologies would treat include attention deficit hyperactivity disorder (ADHD), depression, and epilepsy.

Moreover, NeuroSigma, the California-based medical solutions developer, created the Monarch eTNS System, a non-invasive external trigeminal nerve stimulation (eTNS) device. The Monarch eTNS System is also the first-ever FDA-approved non-drug therapy device for pediatric ADHD treatment.

In addition to this achievement, NeuroSigma aims to carry out more pivotal trials and expand the Monarch eTNS System label. According to the medical solutions developer, the tests would significantly improve treatment for neurological and neuropsychiatric indications.

Enhancing the Digital Therapeutics Ecosystem

“Starting with our strategic partnership with NeuroSigma, we will actively foster and promote digital therapeutics, including electronic drugs, as the basis of new and innovative healthcare businesses,” said Kim Hyung-Wook, Head of KT’s Future Value Promotion Office.

The KT official also noted that although the digital therapy sector in South Korea is still in its infancy, KT aims to expand it. To this end, KT would cultivate the domestic digital therapeutics sector by comprehensively improving its outstanding utility and growth potentials.

Furthermore, KT would design and develop the eTNS solutions’ next-generation versions. KT would also utilize its extensive know-how and capabilities in artificial intelligence (AI), big data, and cloud computing aspects. Additionally, KT would optimize the next-generation products for advanced user experience, design, and functionality.

The telecom would also support advanced AI analysis and monitoring platforms through its digital healthcare ventures. What’s more, KT and NeuroSigma aim to manufacture and commercialize their jointly developed health tech innovations.

KT’s Fast-growing Healthcare Sector Presence

KT, one of the top South Korean digital service providers, had recently been expanding its digital healthcare ecosystem presence. For instance, KT partnered with KAIST to co-develop various ICT-equipped care solutions and services for local vulnerable groups in April.

In late 2020, KT also created a new unit, the Digital and Bio-Health Organization, for its Future Value Promotion Office. KT CEO Koo Hyun-Mo directly controls this division, helping KT advance its digital healthcare platform expansion.

Thanks to its digital healthcare unit, KT formed beneficial ventures with domestic academic associations, biotech firms, hospitals, pharmaceuticals, and more. KT’s network also gives it an unparalleled competitive edge, especially with its new NeuroSigma collaboration.

Leon Ekchian, NeuroSigma’s CEO, commended KT’s electronic health tech expertise, saying that it coincides with NeuroSigma’s electrical and medicine convergence goal. KT also praised the eTNS System, stating that besides being highly effective, the solution provides safe alternatives to drug-based therapies.

Check out other must-read articles from KoreaTechToday:

  • H Robotics Smart Remote Rehabilitation Solution Rebless Wins CES 2021
  • Samsung Promotes AI Healthcare Startups with Ada Health Investment
  • Kakao Diversifies Its Portfolio with 2022 Digital Non-Life Insurance Launch
  • DOUB’s AI-Powered SpeechEMR Automates Medical Transcription
What’s your thoughts?
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
Tags: eTNSKTMonarchMOUneurological conditionsNeuroSigma

Related Posts

South Korea to commercialize Quantum Cryptography Communications
KT signed an MOU with Monarch eTNS System developer NeuroSigma to develop and commercialize electronic treatments for numerous neurological conditions.
Tech Industry

South Korea to commercialize Quantum Cryptography Communications

March 10, 2023
KT Corporation to develop Korea’s Wifi AP Market via Intel MOU
KT signed an MOU with Monarch eTNS System developer NeuroSigma to develop and commercialize electronic treatments for numerous neurological conditions.
KT

KT Corporation to develop Korea’s Wifi AP Market via Intel MOU

March 3, 2023
GC Biopharma to launch first-in-class rare disorder medications in the global market
KT signed an MOU with Monarch eTNS System developer NeuroSigma to develop and commercialize electronic treatments for numerous neurological conditions.
Healthcare

GC Biopharma to launch first-in-class rare disorder medications in the global market

March 2, 2023
South Korea plans Urban Air Mobility Air Taxi services by 2025
KT signed an MOU with Monarch eTNS System developer NeuroSigma to develop and commercialize electronic treatments for numerous neurological conditions.
Tech Industry

South Korea plans Urban Air Mobility Air Taxi services by 2025

February 24, 2023
epilson
KT signed an MOU with Monarch eTNS System developer NeuroSigma to develop and commercialize electronic treatments for numerous neurological conditions.
KT

KT subsidiary Epsilon Telecommunications launches three Points of Presence (PoPs) across South Korea for better connectivity

November 18, 2022
KT and Amazon come together for voice assistance services
KT signed an MOU with Monarch eTNS System developer NeuroSigma to develop and commercialize electronic treatments for numerous neurological conditions.
KT

KT and Amazon come together for voice assistance services

February 12, 2022
No Result
View All Result

Follow Us

FREE NEWSLETTER




PRODUCTS

Most Popular

  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Top South Korean Tech Products to Look Out for in 2021

    0 shares
    Share 0 Tweet 0
  • Robots to help Police Patrol in South Korea

    0 shares
    Share 0 Tweet 0
  • South Korea plans Urban Air Mobility Air Taxi services by 2025

    0 shares
    Share 0 Tweet 0
  • 5 All-Time Best Rom-Com K-Dramas to Watch

    0 shares
    Share 0 Tweet 0
  • SK On to introduce South Korea’s first LFP Battery Prototype

    0 shares
    Share 0 Tweet 0
  • Outsourcing by Samsung to China Feared by Phone Parts Suppliers

    0 shares
    Share 0 Tweet 0
  • Netmarble subsidiary Metaverse Entertainment’s K-Pop virtual girl band MAVE has a smashing online debut

    0 shares
    Share 0 Tweet 0
  • KT Continues to Accelerate Its ‘Digico’ Transformation

    0 shares
    Share 0 Tweet 0
  • Nexon To Reorganize Amid Failing Profits

    0 shares
    Share 0 Tweet 0
  • About Us
  • Account Page
  • application form
  • Cookie policy
  • Default Redirect Page
  • homepage
  • Login
  • login form
  • LogOut
  • Newsletter
  • Privacy Policy
  • Register
  • Reset Password
  • Sample Page
  • Subscription Plan
  • Terms of Use
  • test
  • test
  • testpage
  • TOS Page
  • Visitor Inside User Page

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |